Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study

Table 4 Factors associated with anticoagulant therapy in all patients and those with high risk of stroke (Multivariate logistic regression)

	All patients			patients with high risk of stroke
Variables	B	OR (95% CI)	P value	B	OR (95% CI)	P value
Gender, Female	0.210	1.234 (0.848~1.796)	0.272	0.043	1.044 (0.681~1.601)	0.844
Payment, Self-paying	0.601	1.824 (1.136~2.928)	0.013	0.884	2.234 (1.167~4.277)	0.015
Age (per 1 year increase)	0.029	1.030 (1.010~1.050)	0.003	0.053	1.055 (1.028~1.082)	< 0.001
Education	−0.180	0.835 (0.553~1.260)	0.391	−0.060	0.941 (0.565~1.568)	0.817
AF type, Permanent	−0.902	0.406 (0.206~0.800)	0.009	−0.615	0.541 (0.253~1.157)	0.113
Duration, ≥5 years	0.409	1.505 (1.035~2.189)	0.033	0.286	1.332 (0.863~2.055)	0.196
Severity of symptom	−0.003	0.997 (0.774~1.283)	0.979	0.057	1.059 (0.598~1.874)	0.845
HAS-BLED, score ≥ 3	−0.316	0.729 (0.384~1.385)	0.334	−0.196	0.822 (0.446~1.516)	0.530
CHA₂DS₂-VAS_C, (per 1score increase)	−0.117	0.890 (0.747~1.059)	0.190	−0.058	0.944 (0.736~1.210)	0.647
Hypertension				0.456	1.578 (0.966~2.578)	0.068

Abbreviations: AF Atrial fibrillation, CHA₂DS₂-VASc Congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke, transient ischemic attack, or thromboembolism, vascular disease, age 65–74 years, sex category (female), CI Confidence interval, HAS-BLED Hypertension, abnormal renal and/or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly (age > 65 years), drugs and/or alcohol concomitantly, OR Odds ratio

ISSN: 1471-2261